AKT1 and renal carcinoma: To analyse the functional role of PDK in renal cancer cells, we monitored phospho-AKT (pAKT) status and cell proliferation/viability on Caki-1, A-498, and 786-O ccRCC cell lines, using the pan-PDK inhibitor dichloroacetate (DCA)36.